Compare · ACN vs CPSR
ACN vs CPSR
Side-by-side comparison of Accenture plc (ACN) and Capstar Special Purpose Acquisition Corp. (CPSR): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACN operates in Consumer Discretionary, while CPSR operates in Finance - the two are in different parts of the market.
- ACN carries a market cap of $167.51B.
- ACN has hit the wire 33 times in the past 4 weeks while CPSR has been quiet.
- ACN has more recent analyst coverage (25 ratings vs 0 for CPSR).
- Company
- Accenture plc
- Capstar Special Purpose Acquisition Corp.
- Price
- -
- -
- Market cap
- $167.51B
- -
- 1M return
- +16.29%
- -
- 1Y return
- +0.97%
- -
- Industry
- Business Services
- Business Services
- Exchange
- NYSE
- NYSE
- IPO
- 2001
- 2020
- News (4w)
- 33
- 0
- Recent ratings
- 25
- 0
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
Capstar Special Purpose Acquisition Corp.
Capstar Special Purpose Acquisition Corp. is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was incorporated in 2020 and is based Austin, Texas.
Latest ACN
- SEC Form SCHEDULE 13G filed by Accenture plc
- Strategy/Reinvention Svcs Ofcr Sharma Manish was granted 68 units of Class A ordinary shares, increasing direct ownership by 0.64% to 10,626 units (SEC Form 4)
- Chief Leadership & HR Officer Clifford Katherine Lee was granted 65 units of Class A ordinary shares, increasing direct ownership by 0.93% to 7,058 units (SEC Form 4)
- General Counsel, Corp Sec, CRO Unruch Joel was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.45% to 22,993 units (SEC Form 4)
- CEO-Americas Walsh John F was granted 103 units of Class A ordinary shares, increasing direct ownership by 0.33% to 31,523 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 144 units of Class A ordinary shares, increasing direct ownership by 0.29% to 49,054 units (SEC Form 4)
- Chief Operating Officer Hogan Catherine Kiernan was granted 80 units of Class A ordinary shares, increasing direct ownership by 0.62% to 13,084 units (SEC Form 4)
- Chief Financial Officer Park Angie Y was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.72% to 14,327 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 75 units of Class A ordinary shares, increasing direct ownership by 0.77% to 9,836 units (SEC Form 4)
- Ontario's Workplace Safety and Insurance Board Cuts Employer Registration Time from Days to Minutes with Guidewire
Latest CPSR
- PureTech Health plc – Half-Year Report
- PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
- PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
- PureTech Announces Annual Results for Year Ended December 31, 2021
- SEC Form 4: Cavanaugh Kathryn converted options into 12,825 shares, disposed of 12,825 shares and acquired 12,825 shares
- SEC Form 25-NSE filed by Capstar Special Purpose Acquisition Corp.
- Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
- PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
- Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar
- Capstar Special Purpose Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders